Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial

被引：0
|
作者：
Stephen J. Nicholls
Rishi Puri
Kathy Wolski
Christie M. Ballantyne
Philip J. Barter
H. Bryan Brewer
John J. P. Kastelein
Bo Hu
Kiyoko Uno
Yu Kataoka
Jean-Paul R. Herrman
Bela Merkely
Marilyn Borgman
Steven E. Nissen
机构：
[1] South Australian Health and Medical Research Institute,Department of Cardiovascular Medicine and Cleveland Clinic Coordinating Center for Clinical Research
[2] Cleveland Clinic,Section of Cardiovascular Research
[3] Baylor College of Medicine and the Methodist DeBakey Heart and Vascular Center,Department of Vascular Medicine, Academic Medical Center
[4] University of New South Wales,Department of Cardiology
[5] Medstar Research Institute,Heart and Vascular Center
[6] University of Medicine,undefined
[7] Onze Lieve Vrouwe Gasthuis,undefined
[8] Semmelweis University,undefined
来源：
American Journal of Cardiovascular Drugs | 2016年 / 16卷
关键词：
Atorvastatin; Rosuvastatin; Plaque Burden; Interactive Voice Response; Incremental Benefit;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：55 / 65
页数：10
相关论文
共 50 条
  • [1] Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial
    Nicholls, Stephen J.
    Puri, Rishi
    Wolski, Kathy
    Ballantyne, Christie M.
    Barter, Philip J.
    Brewer, H. Bryan
    Kastelein, John J. P.
    Hu, Bo
    Uno, Kiyoko
    Kataoka, Yu
    Herrman, Jean-Paul R.
    Merkely, Bela
    Borgman, Marilyn
    Nissen, Steven E.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2016, 16 (01) : 55 - 65
  • [2] A Multicenter, Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial of Cytisinicline in Adult Smokers (The ORCA-1 Trial)
    Nides, Mitchell
    Rigotti, Nancy A.
    Benowitz, Neal
    Clarke, Anthony
    Jacobs, Cindy
    NICOTINE & TOBACCO RESEARCH, 2021, 23 (10) : 1656 - 1663
  • [3] A Phase 2b Multicenter, Randomized, Double-Blind, PlaceboControlled Study of OnabotulinumtoxinA for the Treatment of Upper Limb Essential Tremor: ELATE Trial in Progress
    Barbano, Richard
    Simpson, David
    Patterson, Katelin
    Alibhai, Nabilah
    James, Lynn
    TOXICON, 2024, 237 : 6 - 7
  • [4] Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
    Ratziu, V.
    de Guevara, L.
    Safadi, R.
    Poordad, F.
    Fuster, F.
    Flores-Figueroa, J.
    Arrese, M.
    Fracanzani, Anna L.
    Ben Bashat, D.
    Lackner, K.
    Gorfine, T.
    Kadosh, S.
    Oren, R.
    Halperin, M.
    Hayardeny, L.
    Loomba, R.
    Friedman, S.
    Sanyal, Arun J.
    NATURE MEDICINE, 2021, 27 (10) : 1825 - +
  • [5] Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
    V. Ratziu
    L. de Guevara
    R. Safadi
    F. Poordad
    F. Fuster
    J. Flores-Figueroa
    M. Arrese
    Anna L. Fracanzani
    D. Ben Bashat
    K. Lackner
    T. Gorfine
    S. Kadosh
    R. Oren
    M. Halperin
    L. Hayardeny
    R. Loomba
    S. Friedman
    Arun J. Sanyal
    Nature Medicine, 2021, 27 : 1825 - 1835
  • [6] The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity: a multicenter randomized, double-blind, clinical trial (the SPIREN trial)
    Line Aas Mortensen
    Helle C. Thiesson
    Birgitte Tougaard
    Martin Egfjord
    Anne Sophie Lind Fischer
    Claus Bistrup
    BMC Nephrology, 19
  • [7] The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity: a multicenter randomized, double-blind, clinical trial (the SPIREN trial)
    Mortensen, Line Aas
    Thiesson, Helle C.
    Tougaard, Birgitte
    Egfjord, Martin
    Fischer, Anne Sophie Lind
    Bistrup, Claus
    BMC NEPHROLOGY, 2018, 19
  • [8] 2b or not 2b? Shoulder function after level 2b neck dissection: A double-blind randomized controlled clinical trial
    Dziegielewski, Peter T.
    McNeely, Margaret L.
    Ashworth, Nigel
    O'Connell, Daniel A.
    Barber, Brittany
    Courneya, Kerry S.
    Debenham, Brock J.
    Seikaly, Hadi
    CANCER, 2020, 126 (07) : 1492 - 1501
  • [9] Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months -: A multicenter, randomized, double-blind trial
    Schmermund, A
    Achenbach, S
    Budde, T
    Buziashvili, Y
    Förster, A
    Friedrich, G
    Henein, M
    Kerkhoff, G
    Knollmann, F
    Kukharchuk, V
    Lahiri, A
    Leischik, R
    Moshage, W
    Schartl, M
    Siffert, W
    Steinhagen-Thiessen, E
    Sinitsyn, V
    Vogt, A
    Wiedeking, B
    Erbel, R
    CIRCULATION, 2006, 113 (03) : 427 - 437
  • [10] A Phase 2b Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of OnabotulinumtoxinA for the Treatment of Upper Limb Essential Tremor: ELATE Trial
    Patterson, K.
    Alibhai, N.
    Khosla, D.
    James, L.
    MOVEMENT DISORDERS, 2024, 39 : S721 - S721
12345